Comparison of Early Treatment- Emergent Complications of Stage Iii a Non-Small Cell Carcinoma (Nsclc Stage Iii A) in Patients Treated With Neoadjuvant Chemoradiotherapy (Nhlt), (Ncht), and Neoadjuvant Chemotherapy and Adjuvant Radiation Therapy
K. A. Malyarchuk,
A. V. Ganul,
B. O. Borysyuk
et al.
Abstract:Treatment of STAGE III A NSCLC is an extremely difficult problem for modern oncology, since the one-year survival rate from the moment of diagnosis according to the National Cancer Registry is up to 58%. At the same time, there is a situation of uncertainty in the clinical approach to the treatment of this pathology – neither NCCN nor other world scientific literature sources contain information regarding a specific treatment method. The advantage of none of the possible methods of treatment of stage III NSCLC… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.